98 related articles for article (PubMed ID: 15158565)
1. Disruption of sphingolipid biosynthesis in hepatocyte nodules: selective proliferative stimulus induced by fumonisin B1.
van der Westhuizen L; Gelderblom WC; Shephard GS; Swanevelder S
Toxicology; 2004 Jul; 200(1):69-75. PubMed ID: 15158565
[TBL] [Abstract][Full Text] [Related]
2. Loss of sexual differentiation of metabolism of steroids and xenobiotics in nodular hepatic tissue from male and female Wistar rats treated according to the resistant hepatocyte model.
Blanck A; Hällström IP; Eriksson LC
Carcinogenesis; 1990 Jul; 11(7):1067-73. PubMed ID: 2372866
[TBL] [Abstract][Full Text] [Related]
3. Reaction of fumonisin with glucose prevents promotion of hepatocarcinogenesis in female F344/N rats while maintaining normal hepatic sphinganine/sphingosine ratios.
Liu H; Lu Y; Haynes JS; Cunnick JE; Murphy P; Hendrich S
J Agric Food Chem; 2001 Aug; 49(8):4113-21. PubMed ID: 11513718
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ-specific differences in toxin accumulation and sphingoid base metabolism.
Riley RT; Voss KA
Toxicol Sci; 2006 Jul; 92(1):335-45. PubMed ID: 16613836
[TBL] [Abstract][Full Text] [Related]
5. The cancer-promoting potential of fumonisin B1 in rat liver using diethylnitrosamine as a cancer initiator.
Gelderblom WC; Snyman SD; Lebepe-Mazur S; van der Westhuizen L; Kriek NP; Marasas WF
Cancer Lett; 1996 Dec; 109(1-2):101-8. PubMed ID: 9020908
[TBL] [Abstract][Full Text] [Related]
6. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
7. Antinutritional effects of fumonisin B1 and pathophysiological consequences.
Carratù MR; Cassano T; Coluccia A; Borracci P; Cuomo V
Toxicol Lett; 2003 Apr; 140-141():459-63. PubMed ID: 12676494
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different initiation protocols in the resistant hepatocyte model.
Espandiari P; Robertson LW; Srinivasan C; Glauert HP
Toxicology; 2005 Jan; 206(3):373-81. PubMed ID: 15588927
[TBL] [Abstract][Full Text] [Related]
9. Effects of orally administered fumonisin B₁ (FB₁), partially hydrolysed FB₁, hydrolysed FB₁ and N-(1-deoxy-D-fructos-1-yl) FB₁ on the sphingolipid metabolism in rats.
Hahn I; Nagl V; Schwartz-Zimmermann HE; Varga E; Schwarz C; Slavik V; Reisinger N; Malachová A; Cirlini M; Generotti S; Dall'Asta C; Krska R; Moll WD; Berthiller F
Food Chem Toxicol; 2015 Feb; 76():11-8. PubMed ID: 25475052
[TBL] [Abstract][Full Text] [Related]
10. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
[TBL] [Abstract][Full Text] [Related]
11. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
13. Fumonisin B(1): oxidative status and DNA damage in rats.
Domijan AM; Zeljezić D; Milić M; Peraica M
Toxicology; 2007 Apr; 232(3):163-9. PubMed ID: 17291664
[TBL] [Abstract][Full Text] [Related]
14. Induction of an altered lipid phenotype by two cancer promoting treatments in rat liver.
Riedel S; Abel S; Swanevelder S; Gelderblom WC
Food Chem Toxicol; 2015 Apr; 78():96-104. PubMed ID: 25656646
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sphingolipids in Wistar rats treated to prolonged and single oral doses of fumonisin b₁.
Direito GM; Almeida AP; Aquino S; Alves Dos Reis T; Rodrigues Pozzi C; Corrêa B
Int J Mol Sci; 2009 Jan; 10(1):50-61. PubMed ID: 19333435
[TBL] [Abstract][Full Text] [Related]
16. Cancer initiation by fumonisin B(1) in rat liver--role of cell proliferation.
Gelderblom WC; Galendo D; Abel S; Swanevelder S; Marasas WF; Wild CP
Cancer Lett; 2001 Aug; 169(2):127-37. PubMed ID: 11431101
[TBL] [Abstract][Full Text] [Related]
17. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
He Q; Kim J; Sharma RP
Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
[TBL] [Abstract][Full Text] [Related]
18. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
Rentz SS; Showker JL; Meredith FI; Riley RT
Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
[TBL] [Abstract][Full Text] [Related]
20. The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.
Zacharias C; van Echten-Deckert G; Wang E; Merrill AH; Sandhoff K
Glycoconj J; 1996 Apr; 13(2):167-75. PubMed ID: 8737241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
